Patients with cancer are increasingly having tumor DNA sequenced to identify disease markers and potential targets, but some investigators question whether every cancer patient can benefit.
In recent years, the use of genomic sequencing panels in cancer treatment has become widespread. These are tests that search the DNA of the patient s tumor for gene variants for which validated drugs are known, making the treatment more personalized and therefore more effective. They are part of what is known as precision oncology.